首页 > 最新文献

Journal of Heart Valve Disease最新文献

英文 中文
Multiple Valve Disease 多瓣膜病
Q3 Medicine Pub Date : 2019-11-13 DOI: 10.1007/978-3-030-23104-0_13
P. Unger, M. Pepi
{"title":"Multiple Valve Disease","authors":"P. Unger, M. Pepi","doi":"10.1007/978-3-030-23104-0_13","DOIUrl":"https://doi.org/10.1007/978-3-030-23104-0_13","url":null,"abstract":"","PeriodicalId":50184,"journal":{"name":"Journal of Heart Valve Disease","volume":"68 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79370567","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tricuspid Valve Disease 三尖瓣疾病
Q3 Medicine Pub Date : 2019-11-13 DOI: 10.1007/978-3-030-23104-0_9
R. Hahn
{"title":"Tricuspid Valve Disease","authors":"R. Hahn","doi":"10.1007/978-3-030-23104-0_9","DOIUrl":"https://doi.org/10.1007/978-3-030-23104-0_9","url":null,"abstract":"","PeriodicalId":50184,"journal":{"name":"Journal of Heart Valve Disease","volume":"16 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80060262","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acute Rheumatic Fever and Rheumatic Heart Disease 急性风湿热和风湿性心脏病
Q3 Medicine Pub Date : 2019-11-13 DOI: 10.1007/978-3-030-23104-0_11
G. Itzikowitz, E. A. Prendergast, B. D. Prendergast, L. Zühlke
{"title":"Acute Rheumatic Fever and Rheumatic Heart Disease","authors":"G. Itzikowitz, E. A. Prendergast, B. D. Prendergast, L. Zühlke","doi":"10.1007/978-3-030-23104-0_11","DOIUrl":"https://doi.org/10.1007/978-3-030-23104-0_11","url":null,"abstract":"","PeriodicalId":50184,"journal":{"name":"Journal of Heart Valve Disease","volume":"38 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76029032","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Range of Pulmonary Autograft Responses to Systemic Pressure Immediately After Ross Procedure. 罗斯手术后自体肺移植物对体压的反应范围。
Q3 Medicine Pub Date : 2019-01-01
Andrew D Wisneski, Zhongjie Wang, Yue Xuan, Julius M Guccione, Liang Ge, Elaine E Tseng

Background: Pulmonary autograft dilatation after Ross operation often necessitates reoperation. To understand autograft remodeling, a biomechanical understanding of human autografts after exposure to systemic pressure is required. We previously developed an ex vivo human pulmonary autograft finite element (FE) model to predict wall stress after exposure to systemic pressure. However, autograft material properties vary significantly among individuals. Our study aim was to quantify range of wall stress changes in a human autograft after Ross operation prior to remodeling based upon normal variation in human autograft mechanical properties.

Methods: A normal human autograft FE model was loaded to pulmonary and systemic arterial pressures. Stress-strain data of normal human autografts (n=24) were incorporated into an Ogden hyper-elastic model to describe autograft mechanical behavior. Autograft wall stresses at pulmonary vs. systemic pressures were examined. Autograft volume-based stress analysis was performed, based on percentage of autograft element volume exceeding 1 standard deviation (SD) above group mean stress at systemic systole.

Results: Mean first principal wall stresses (FPS) at systole of systemic versus pulmonary pressures were 129.29±17.47kPa versus 24.42±3.85kPa (p<0.001) at the annulus, 187.53±20.06kPa versus 35.98±2.15kPa at sinuses (p<0.001), and 268.68±23.40kPa versus 50.15±5.90kPa (p<0.001) at sinotubuluar junction (STJ). The percentage of autograft element volume that exceeded one SD above the group mean was 14.3±5.6% for FPS and 12.6±10.1% for second principal stresses.

Conclusion: We quantified normal human autograft biomechanical responses to systemic pressure based on patient-specific material properties. Regions of peak stresses were observed in autograft sinuses and STJ regions, which corresponded clinically to locations of autograft dilation. Our results provide valuable information on predicting variations in patient-specific ex vivo FE models when population-based material properties are used in settings where patient-specific properties are unknown.

背景:罗斯手术后自体肺移植扩张常常需要再次手术。为了理解自体移植物的重塑,需要了解人体自体移植物暴露于全身压力后的生物力学。我们之前开发了一个离体人体自体肺移植有限元(FE)模型来预测暴露于全身压力后的壁应力。然而,自体移植物材料的性能在个体之间差异很大。我们的研究目的是根据人体自体移植物力学性能的正常变化,量化罗斯手术后重塑前人体自体移植物壁应力变化的范围。方法:将正常人体自体移植FE模型加载肺动脉压和全身动脉压。将正常人体自体移植物(n=24)的应力应变数据纳入Ogden超弹性模型,以描述自体移植物的力学行为。研究了自体移植物在肺压力和全身压力下的壁应力。基于自体移植物体积的应力分析,基于自体移植物体积超过系统收缩期组平均应力1个标准差(SD)的百分比。结果:收缩期全身压力和肺压力的平均第一主壁应力(FPS)分别为129.29±17.47kPa和24.42±3.85kPa。结论:基于患者特异性材料特性,我们量化了正常人体自体移植物对全身压力的生物力学反应。在自体移植物鼻窦和STJ区观察到应力峰值区域,这些区域在临床上与自体移植物扩张的位置相对应。我们的研究结果为预测患者特异性体外FE模型的变化提供了有价值的信息,当基于群体的材料特性在患者特异性特性未知的情况下使用时。
{"title":"Range of Pulmonary Autograft Responses to Systemic Pressure Immediately After Ross Procedure.","authors":"Andrew D Wisneski,&nbsp;Zhongjie Wang,&nbsp;Yue Xuan,&nbsp;Julius M Guccione,&nbsp;Liang Ge,&nbsp;Elaine E Tseng","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Pulmonary autograft dilatation after Ross operation often necessitates reoperation. To understand autograft remodeling, a biomechanical understanding of human autografts after exposure to systemic pressure is required. We previously developed an <i>ex vivo</i> human pulmonary autograft finite element (FE) model to predict wall stress after exposure to systemic pressure. However, autograft material properties vary significantly among individuals. Our study aim was to quantify range of wall stress changes in a human autograft after Ross operation prior to remodeling based upon normal variation in human autograft mechanical properties.</p><p><strong>Methods: </strong>A normal human autograft FE model was loaded to pulmonary and systemic arterial pressures. Stress-strain data of normal human autografts (n=24) were incorporated into an Ogden hyper-elastic model to describe autograft mechanical behavior. Autograft wall stresses at pulmonary vs. systemic pressures were examined. Autograft volume-based stress analysis was performed, based on percentage of autograft element volume exceeding 1 standard deviation (SD) above group mean stress at systemic systole.</p><p><strong>Results: </strong>Mean first principal wall stresses (FPS) at systole of systemic versus pulmonary pressures were 129.29±17.47kPa versus 24.42±3.85kPa (p<0.001) at the annulus, 187.53±20.06kPa versus 35.98±2.15kPa at sinuses (p<0.001), and 268.68±23.40kPa versus 50.15±5.90kPa (p<0.001) at sinotubuluar junction (STJ). The percentage of autograft element volume that exceeded one SD above the group mean was 14.3±5.6% for FPS and 12.6±10.1% for second principal stresses.</p><p><strong>Conclusion: </strong>We quantified normal human autograft biomechanical responses to systemic pressure based on patient-specific material properties. Regions of peak stresses were observed in autograft sinuses and STJ regions, which corresponded clinically to locations of autograft dilation. Our results provide valuable information on predicting variations in patient-specific <i>ex vivo</i> FE models when population-based material properties are used in settings where patient-specific properties are unknown.</p>","PeriodicalId":50184,"journal":{"name":"Journal of Heart Valve Disease","volume":"28 1","pages":"22-31"},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8592523/pdf/nihms-1747639.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39629676","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antithrombotic Therapy in Valvular Heart Disease 瓣膜性心脏病的抗血栓治疗
Q3 Medicine Pub Date : 2019-01-01 DOI: 10.1007/978-3-030-23104-0_16
S. Droogmans, S. Vanhentenrijk, B. Cosyns
{"title":"Antithrombotic Therapy in Valvular Heart Disease","authors":"S. Droogmans, S. Vanhentenrijk, B. Cosyns","doi":"10.1007/978-3-030-23104-0_16","DOIUrl":"https://doi.org/10.1007/978-3-030-23104-0_16","url":null,"abstract":"","PeriodicalId":50184,"journal":{"name":"Journal of Heart Valve Disease","volume":"85 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76339015","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Introduction to Valve Heart Disease 瓣膜性心脏病简介
Q3 Medicine Pub Date : 2019-01-01 DOI: 10.1007/978-3-030-23104-0_1
J. Zamorano, Á. M. D. Castillo
{"title":"Introduction to Valve Heart Disease","authors":"J. Zamorano, Á. M. D. Castillo","doi":"10.1007/978-3-030-23104-0_1","DOIUrl":"https://doi.org/10.1007/978-3-030-23104-0_1","url":null,"abstract":"","PeriodicalId":50184,"journal":{"name":"Journal of Heart Valve Disease","volume":"36 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89635398","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Aortic Valve Intraoperative Echocardiography 主动脉瓣术中超声心动图
Q3 Medicine Pub Date : 2019-01-01 DOI: 10.1007/978-3-030-23104-0_5
C. Fernández-Golfín
{"title":"Aortic Valve Intraoperative Echocardiography","authors":"C. Fernández-Golfín","doi":"10.1007/978-3-030-23104-0_5","DOIUrl":"https://doi.org/10.1007/978-3-030-23104-0_5","url":null,"abstract":"","PeriodicalId":50184,"journal":{"name":"Journal of Heart Valve Disease","volume":"30 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84279185","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evolution of Bilateral Mammary Arterial Grafting Program in Veterans Affairs Medical Center. 退伍军人医疗中心双侧乳腺动脉移植项目的发展。
Q3 Medicine Pub Date : 2019-01-01
Sue X Wang, Michelle Lee, Chih-Chiun Chang, Lillian Y Y Lai, Nick Flores, Liang Ge, Curtis J Wozniak, Elaine E Tseng

Background: Coronary revascularization with bilateral internal mammary arteries is associated with increased long-term survival, but underutilized due to sternal wound infection concerns. Dedicated bilateral mammary grafting programs are typically high-volume academic or private practices, rather than lower-volume federal institutions whose results are not captured in the Society of Thoracic Surgeons database. Our institution used only single internal mammary arterial grafting in the year prior to implementing a dedicated bilateral grafting program using skeletonized technique. We describe our experience transitioning to bilateral mammary grafting and its impact on sternal wound infection.

Methods: Retrospective cohort study at San Francisco Veterans Affairs Medical Center in 200 patients undergoing first-time isolated, multi-vessel coronary artery bypass from August 2014 to October 2017. Sternal wound infection was defined broadly to include any patient receiving antibiotics for suspicion of sternal infection. Patients were followed for wound complications until 3 post-operative months.

Results: Of 200 total patients, 45.5% (n=91) were diabetic, 44% (n=88) had BMI >30, and 61.5% (n=123) underwent bilateral mammary grafting. Bilateral mammary grafting population had 2.4% (n=3/123) deep sternal wound infection with 1.6% (n=2/123) requiring sternal reconstruction while single mammary population had 1.3% (n=1/77, p=1.0). Bilateral mammary grafting population had 6.5% (n=8/123) superficial sternal wound infection compared to 5.2% (n=4/77, p=0.77) in single mammary grafting population.

Conclusions: Transitioning to high rates of bilateral mammary utilization was possible in a year with low rates of complications. Based on our experience, surgeons should consider adopting a skeletonized bilateral mammary grafting approach given potential long-term survival benefit.

背景:双侧乳腺内动脉冠状动脉血运重建术可提高长期生存率,但由于担心胸骨伤口感染而未得到充分利用。专门的双侧乳房移植项目通常是大量的学术或私人实践,而不是规模较小的联邦机构,这些机构的结果没有被胸外科学会的数据库所记录。我们的机构在实施专用的双侧骨化技术移植计划之前,仅使用过单侧乳腺内动脉移植。我们描述了我们的经验过渡到双侧乳房移植和其影响胸骨伤口感染。方法:回顾性队列研究2014年8月至2017年10月在旧金山退伍军人事务医疗中心接受首次孤立多支冠状动脉搭桥术的200例患者。胸骨伤口感染定义广泛,包括任何因怀疑胸骨感染而接受抗生素治疗的患者。术后3个月随访伤口并发症。结果:200例患者中,45.5% (n=91)为糖尿病患者,44% (n=88) BMI >30, 61.5% (n=123)行双侧乳房移植。双侧乳房移植人群胸骨深创面感染2.4% (n=3/123),需要重建胸骨1.6% (n=2/123),单侧乳房人群为1.3% (n=1/77, p=1.0)。双侧乳房移植组胸骨浅表伤口感染发生率为6.5% (n=8/123),单侧乳房移植组为5.2% (n=4/77, p=0.77)。结论:双侧乳腺利用率高,并发症发生率低,可以在一年内实现过渡。根据我们的经验,外科医生应该考虑采用骨化双侧乳房移植方法,以获得潜在的长期生存益处。
{"title":"Evolution of Bilateral Mammary Arterial Grafting Program in Veterans Affairs Medical Center.","authors":"Sue X Wang,&nbsp;Michelle Lee,&nbsp;Chih-Chiun Chang,&nbsp;Lillian Y Y Lai,&nbsp;Nick Flores,&nbsp;Liang Ge,&nbsp;Curtis J Wozniak,&nbsp;Elaine E Tseng","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Coronary revascularization with bilateral internal mammary arteries is associated with increased long-term survival, but underutilized due to sternal wound infection concerns. Dedicated bilateral mammary grafting programs are typically high-volume academic or private practices, rather than lower-volume federal institutions whose results are not captured in the Society of Thoracic Surgeons database. Our institution used only single internal mammary arterial grafting in the year prior to implementing a dedicated bilateral grafting program using skeletonized technique. We describe our experience transitioning to bilateral mammary grafting and its impact on sternal wound infection.</p><p><strong>Methods: </strong>Retrospective cohort study at San Francisco Veterans Affairs Medical Center in 200 patients undergoing first-time isolated, multi-vessel coronary artery bypass from August 2014 to October 2017. Sternal wound infection was defined broadly to include any patient receiving antibiotics for suspicion of sternal infection. Patients were followed for wound complications until 3 post-operative months.</p><p><strong>Results: </strong>Of 200 total patients, 45.5% (n=91) were diabetic, 44% (n=88) had BMI >30, and 61.5% (n=123) underwent bilateral mammary grafting. Bilateral mammary grafting population had 2.4% (n=3/123) deep sternal wound infection with 1.6% (n=2/123) requiring sternal reconstruction while single mammary population had 1.3% (n=1/77, p=1.0). Bilateral mammary grafting population had 6.5% (n=8/123) superficial sternal wound infection compared to 5.2% (n=4/77, p=0.77) in single mammary grafting population.</p><p><strong>Conclusions: </strong>Transitioning to high rates of bilateral mammary utilization was possible in a year with low rates of complications. Based on our experience, surgeons should consider adopting a skeletonized bilateral mammary grafting approach given potential long-term survival benefit.</p>","PeriodicalId":50184,"journal":{"name":"Journal of Heart Valve Disease","volume":"28 2","pages":"59-66"},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8568483/pdf/nihms-1747637.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39596830","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of Patients with Heart Valve Disease 心脏瓣膜病患者的评价
Q3 Medicine Pub Date : 2019-01-01 DOI: 10.1007/978-3-030-23104-0_2
J. Zamorano, C. Santoro, Á. M. D. Castillo
{"title":"Evaluation of Patients with Heart Valve Disease","authors":"J. Zamorano, C. Santoro, Á. M. D. Castillo","doi":"10.1007/978-3-030-23104-0_2","DOIUrl":"https://doi.org/10.1007/978-3-030-23104-0_2","url":null,"abstract":"","PeriodicalId":50184,"journal":{"name":"Journal of Heart Valve Disease","volume":"32 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89893953","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Heart Valve Diseases in Pregnancy 妊娠期心脏瓣膜疾病
Q3 Medicine Pub Date : 2019-01-01 DOI: 10.1007/978-3-030-23104-0_17
D. Muraru, E. Surkova
{"title":"Heart Valve Diseases in Pregnancy","authors":"D. Muraru, E. Surkova","doi":"10.1007/978-3-030-23104-0_17","DOIUrl":"https://doi.org/10.1007/978-3-030-23104-0_17","url":null,"abstract":"","PeriodicalId":50184,"journal":{"name":"Journal of Heart Valve Disease","volume":"29 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76541035","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Heart Valve Disease
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1